期刊文献+

ABC分型法对急性起病1型糖尿病亚型诊断的研究 被引量:10

Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients
原文传递
导出
摘要 目的探讨ABC分型法对急性起病1型糖尿病亚型诊断的可行性及其诊断界值。方法用放射配体法检测308例急性起病1型糖尿病患者谷氨酸脱羧酶抗体(GAD—Ab)和酪氨酸磷酸酶抗体(IA-2A),根据抗体阳性与否分为A+组(任一抗体阳性)和A-组(抗体皆为阴性)。比较A+和A-组临床特征、胰岛功能变化及HLA—DQ易感基因型的差异,判断胰岛自身抗体对急性起病1型糖尿病分型诊断的价值。进一步以随访2年时胰岛素用量作为标准(〈20U/d或≥20U/d),通过绘制ROC曲线来判断在A+和A-患者中,用空腹C肽、体质指数和HLA—DQ基因型进一步分型的可能性和最佳诊断截点。分析ABC分型法各亚型患者的临床特点。结果胰岛自身抗体可将急性起病1型糖尿病分为临床特征完全不同的A+和A-两组,是分型诊断的首选指标。空腹C肽在A+和A-两组患者中均可进一步分型,A+患者的最佳诊断截点为150pmol/L,而A-患者为250pmol/L。体质指数在A-患者中可进一步分型诊断,最佳截点为24kg/m^2,而在A十患者中无此作用。HLA—DQ易感基因型在A+和A-两组患者中均无进一步分型诊断的价值。结论ABC分型法可对急性起病的1型糖尿病患者进行亚型诊断,有助于判断预后。 Objective To investigate the feasibility of ABC typing to redefine the subtypes of acuteonset type 1 diabetes meUitus (DM). Methods Radioligand assay was used to detect glutamic acid decarboxylase-antibedy (GAD-Ab) and tyrosine phosphatase autoantibedy (IA-2A) in 308 patients with acute-onset type 1 DM. The patients were thus divided into 2 groups: pancreatic islet auto-antibedy (demonstrated as A) positive group---positive in GAD-Ab or IA-2A--and pancreatic islet auto-antibedy negative group. The clinical features and frequencies of HLA-DQ genotypes of these groups were compared. Within 24 hours after the correction of diabetic ketosis or diabetic ketoacidosis and after fasting for at least 8 h fasting and postprandial venous blood samples were collected to detect the fasting C peptide ( FCP, demonstrated as B) reflecting the beta cell function, and postprandial C peptide (PCP). The patients were followed up for 2 years to know the insulin dosage ( 〈 20 U/d or ≥ 20 U/d). Receiver operating characteristic curve (ROC) was drawn to judge the values of fasting C peptide, body mass index ( BMI, demonstrated as C) reflecting the central obesity, and HLA-DQ genotype in further typing among the A + and A - patients and the optimal cutoff points thereof. Results Compared with the A - group, the metabolic disorders at the onset were more severe, the insulin dosage at the 2-year follow-up was higher, and the percentage of susceptible HLA-DQ genotypo was higher in the A + group (P 〈 0.05 or 〈 0.01 ). The level of FCP (B) could be used to further subtyping in both A + and A - groups, with the optimal cutoff point of 150 pmol/L in the A + group and with the optimal cutoff point of 250 pmol/L in the A - group. BMI could be used for further classification in only A - group with the optimal cutoff point of 24 kg/m^2.HLA-DQ genotypes were of little value in further classification both in A + and A - groups. Conclusion ABC typing may be used as a new way to redefine t
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第12期797-801,共5页 National Medical Journal of China
基金 国家自然科学基金资助项目(30370681) 卫生部人才专项基金资助项目(Q9420) 教育部跨世纪人才基金资助项目(2002-48) 湖南省卫生厅科研重点项目基金资助项目(A2004-004)
关键词 糖尿病 1型 自身抗体 体质指数 Diabetes mellitus, type 1 Autoantibodies Body mass index
  • 相关文献

参考文献13

  • 1World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999. 被引量:1
  • 2Kitabchi AE, Umpierrez GE, Murphy MB, et al. American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care. 2004, 27 Suppl 1:S94-102. 被引量:1
  • 3周智广.特发性1型糖尿病的诊断及鉴别的临床意义[J].中国糖尿病杂志,2003,11(3):158-158. 被引量:7
  • 4李霞,周智广,黄干,彭健,颜湘,王建平,杨琳.罗格列酮与胰岛素合用对LADA患者胰岛β细胞功能保护作用的初步观察[J].中国糖尿病杂志,2003,11(4):242-246. 被引量:63
  • 5Siraj ES, Reddy SS, Scherbaum WA, et al. Basal and postglucagon C-peptide levels in Ethiopians with diabetes. Diabetes Care, 2002, 25:453-457. 被引量:1
  • 6Palmer JP, Fleming GA, Greenbanm CJ, et al. C-poptide is the appropriate outcome measure, for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes, 2004, 53:250-264. 被引量:1
  • 7周智广,张弛,张冬梅,黄干,王建平,林健.特发性1型糖尿病的临床特征及其亚型诊断探讨[J].中华糖尿病杂志(1006-6187),2004,12(2):79-85. 被引量:37
  • 8Atkinsen MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 2001, 358: 221-229. 被引量:1
  • 9Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev, 2002, 18:192-200. 被引量:1
  • 10Gillespie KM, Bain SC, Barnett AH, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet, 2004,364 : 1699-1700. 被引量:1

二级参考文献25

  • 1王姮,何瑞娟.HLA-DQA_1、-DQB_1等位基因在IDDM易感性中的作用[J].中华内分泌代谢杂志,1993,9(4):202-204. 被引量:14
  • 2王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 3[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80. 被引量:1
  • 4[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459. 被引量:1
  • 5[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189. 被引量:1
  • 6[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249. 被引量:1
  • 7[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626. 被引量:1
  • 8[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130. 被引量:1
  • 9[8]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev,2002,18:114-117. 被引量:1
  • 10Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care.1997,20:1183-1197. 被引量:2

共引文献102

同被引文献88

引证文献10

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部